(225 ILCS 120/5) (from Ch. 111, par. 8301-5)
    (Section scheduled to be repealed on January 1, 2023)
    Sec. 5. Scope. This Act applies to any person, partnership, corporation, or business firm engaging in the wholesale distribution of human prescription drugs within this State.
(Source: P.A. 87-594.)